Skip to content

Cardifix Endocardial Pacing Lead

by Intermedics, Inc. 510(k)

Active United States

510(k) K922042

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESP Substantially Equivalent — Postmarket Surveillance · Traditional NumberK922042 Date29 Apr 1993ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESP Substantially Equivalent — Postmarket Surveillance

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Cardifix Endocardial Pacing Lead is a Permanent Pacemaker Electrode, designed for endocardial placement within the heart to deliver electrical stimulation for cardiac pacing. It facilitates synchronized contraction of the heart chambers, addressing bradycardia or conduction disorders by transmitting pacing impulses directly to myocardial tissue.

This device is supplied sterile and intended for single-use, adhering to Class III regulatory standards under FDA 510(k) clearance (K922042). It is intended for use in cardiac electrophysiology procedures, with specific attention to sterility and proper handling to ensure patient safety. The lead is compatible with MRI environments under defined conditions, as outlined in its technical specifications.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Cardifix Endocardial Pacing Lead used for in clinical practice?

    The Cardifix Endocardial Pacing Lead is designed for endocardial placement within the heart to deliver electrical stimulation for cardiac pacing. It helps synchronize heart chamber contractions, addressing conditions like bradycardia or conduction disorders by transmitting pacing impulses directly to the myocardial tissue.

  • Is the Cardifix Endocardial Pacing Lead intended for single-use or reusable applications?

    The Cardifix Endocardial Pacing Lead is explicitly supplied sterile and intended for single-use only. This ensures patient safety and adheres to regulatory standards for Class III medical devices.

  • How should the Cardifix Endocardial Pacing Lead be stored before use?

    While the provided data does not specify exact storage conditions, the lead is supplied sterile, so it must be stored in its original, unopened packaging to maintain sterility until immediately before use. Always follow manufacturer guidelines for handling and storage.

  • Can this device be used in patients who require MRI scans?

    Yes, the Cardifix Endocardial Pacing Lead is compatible with MRI environments under defined conditions. However, the specific MRI safety parameters (e.g., magnetic field strength, imaging sequences) must be reviewed and followed as outlined in the device’s technical specifications to ensure patient safety.

  • What regulatory pathway was followed for FDA clearance of this device?

    The Cardifix Endocardial Pacing Lead received FDA 510(k) clearance (K922042) under the traditional review pathway, classified as a Class III device. The submission was reviewed by the FDA’s Cardiovascular (CV) Advisory Committee, and the decision was made under the Special Emergency Submission Procedure (SESP) in 1993.